12/14/2011 Nu Skin Enterprises Acquires LifeGen Technologies
Press Release
10/21/2010 - LifeGen Technologies awarded Phase I SBIR grant from the National Institute on Aging
More information here
10/22/2009 - Nu Skin signs Research Agreement with LifeGen Technologies
LifeGen Co-founder Richard Weindruch featured on CBS's 60 Minutes news story on resveratrol and calorie
restriction
1/25/2009 Link
to story and video
LifeGen researchers report that consumption of a low dose of the red wine molecule resveratrol mimics the gene
expression profile of mice subjected to a calorie-restricted diet.
6/4/2008 - PLoS
ONE
At this time, LifeGen Technologies LLC has elected not to disclose the details of our present patents and three pending patents.
The company will reveal that these patents collectively represent unique technologies and gene targets that allow a scientific approach to the development of molecular therapies to prevent and treat the diseases associated with aging.
LifeGen is in discussions with potential investors so that it may expand the scope and depth of its R&D program.